Skip to content
TirzepatideReport
Providers

Tracked provider

SkinnyRx tirzepatide review

Consult and overnight shipping folded into the price — and an FDA warning letter on the record.

This is a tracked entry: the facts below are what SkinnyRx publishes about itself, recorded and re-checked as part of the board we maintain (last checked 2026-07-10). Our hand-written reviews go deeper on the programs people ask about most. Prices change — confirm on SkinnyRx's own site before you pay.

What it costs

Tirzepatide
Compounded tirzepatide advertised 'as low as $224.25/month' — a floor rather than a flat rate — for either the once-weekly injection or the once-daily tablet, with brand Mounjaro and Zepbound listed separately at $1,400/month
What is dispensed
Compounded tirzepatide (injectable and tablet), with a microdose option
Who compounds it
Unspecified

How the program works

A telehealth weight-loss programme prescribing compounded semaglutide and tirzepatide through licensed US clinicians, with the consultation and free overnight shipping bundled into a monthly cash price and a microdosing option available. The advertised figures are described as 'as low as' rather than flat, so the number you see is the bottom of a range whose top is not published. SkinnyRx received an FDA warning letter (#717989) dated 20 February 2026; the letter and its date are stated here because the roster records them, and readers should read the letter itself rather than our summary of what it alleges.

What we like

  • The consultation and free overnight shipping are included in the monthly price rather than billed separately
  • Both compounded semaglutide and compounded tirzepatide, with a microdose option
  • Tiered monthly pricing published from $199/month upward
  • Cancel any time, with discreet shipping included

The caveats

  • FDA warning letter #717989, dated 20 February 2026 — read the letter at fda.gov rather than any summary of it
  • Pricing is quoted 'as low as', so $224.25 is a floor and the price of a titrated dose is not published
  • States served are not publicly disclosed and sit behind the signup intake
  • Limited public information about the programme, the clinicians, or the compounding pharmacy
  • Brand Mounjaro and Zepbound are listed at $1,400/month, far above LillyDirect self-pay vials

Ready to look at SkinnyRx directly? The link below is tracked so we can see it worked; it goes to their own site.

Visit SkinnyRx

Advertising disclosure — some, not all, of the providers ranked here are partners, and we may earn a commission at no additional cost to you. The prices and facts we report come from each provider's own published program. Full disclosure.

Other tirzepatide programs we track

← Every provider review